# Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia

> **NCT02120781** · PHASE2 · COMPLETED · sponsor: **Castle Creek Biosciences, LLC.** · enrollment: 21 (actual)

## Conditions studied

- Dysphonia Resulting From Vocal Fold Scarring
- Age-related Dysphonia

## Interventions

- **BIOLOGICAL:** Azficel-T (autologous fibroblasts)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02120781
- **Lead sponsor:** Castle Creek Biosciences, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-12-21
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120781, "Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02120781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*